Business Development Executive Director (Hyperscaler Partnerships) Iridium Satellite, LLCBusiness Development Executive Director (Hyperscaler Partnerships)Redwood City, California$280,000–$335,000 / yearPosition Summary, Job Requirements & Responsibilities: What We’re Looking For: If you have deep experience operating within the Big Tech ecosystem and leading strategic, high‑value partnerships with hyperscalers and OEMs, you will be excited about the Executive Director, Hyperscaler & OEM Partnerships role with Iridium. Foster and develop a highly effective cross functional engagement model between Iridium/Authentic leadership, engineering, product, and hyperscaler/OEM executive stakeholders to accelerate partnership outcomes.
Executive Director of Product, Growth & Monetization The Walt Disney CompanyExecutive Director of Product, Growth & MonetizationSan Francisco, CaliforniaJob Posting Segment: Disney Entertainment and ESPN Product & Technology Job Posting Primary Business: Commerce, Data & Identity Primary Job Posting Category: Product Management Tech Employment Type: Full time Primary City, State, Region, Postal Code: San Francisco, CA, USA Alternate City, State, Region, Postal Code: USA - CA - 1200 Grand Central Ave Date Posted: 2025-11-12 Disney Entertainment and ESPN Product & Technology is a global organization of engineers, product developers, designers, technologists, data scientists, and more – all working to build and advance the technological backbone for Disney’s media business globally.
Relationship Executive - Technology Fintech & Payments Banking - Executive Director JPMorgan Chase Bank, N.A.Relationship Executive - Technology Fintech & Payments Banking - Executive DirectorSan Francisco, CAFull timeOur history spans over 200 years and today we are a leader in investment banking, consumer and small business banking, commercial banking, financial transaction processing and asset management. As a Relationship Executive on the Technology Fintech & Payments Banking team, you will be responsible for growing and retaining profitable relationships within the Commercial & Specialized Industries group specializing in Technology Fintech & Payments Banking.
Relationship Executive - Life Sciences Banking - Executive Director JPMorgan Chase Bank, N.A.Relationship Executive - Life Sciences Banking - Executive DirectorSan Francisco, CAFull timeOur history spans over 200 years and today we are a leader in investment banking, consumer and small business banking, commercial banking, financial transaction processing and asset management. JPMorganChase, one of the oldest financial institutions, offers innovative financial solutions to millions of consumers, small businesses and many of the world's most prominent corporate, institutional and government clients under the J.P.
Executive Director & Head Clinical Data Management Annexon, Inc.Executive Director & Head Clinical Data ManagementSan Francisco, CARemote$301,500–$330,000 / yearOur novel scientific approach targets upstream C1q to block the classical complement inflammatory cascade before it starts, and its therapeutic candidates are designed to provide meaningful benefits across multiple autoimmune, neurodegenerative and ophthalmic diseases. Company: At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye.
Infrastructure Platform Experience Design, Executive Director JPMorgan Chase Bank, N.A.Infrastructure Platform Experience Design, Executive DirectorPalo Alto, CAFull timeYou will partner closely with technical product managers, solution architects, and network/platform engineers to ensure experiences are coherent across platform surfaces (UI, workflows, APIs touchpoints, documentation and support journeys) and grounded in how infrastructure users actually work. Lead and elevate the end-to-end customer experience for Infrastructure Platforms by managing a team of designers who deliver user experiences for backend infrastructure products and services (e.g., networking, compute, storage, database, cloud platform capabilities).
Executive Director of Campus Operations - Administration and Finance CSU CareersExecutive Director of Campus Operations - Administration and FinanceVallejo, CaliforniaThe Administration and Finance Division plays a vital role in supporting the university’s operational backbone, encompassing areas such as finance, budgeting, facilities, public safety, environmental health and safety, procurement, University Housing, Information Technology Services, Performing Arts Center, Cal Poly Partners, and divisional operations. The SVP of Administration and Finance reports directly to the University President and serves as a member of the President’s Cabinet, working collaboratively with other university divisions to advance strategic initiatives, ensure financial sustainability, and maintain a safe, inclusive, and well-functioning campus environment.
Executive Director, GCP QA (Good Clinical Practice, Quality Assurance) Revolution Medicines, Inc.Executive Director, GCP QA (Good Clinical Practice, Quality Assurance)Redwood City, CA$265,000–$331,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Minimum of 15 years of experience in the pharmaceutical or biotechnology industry, including at least 10 years in GCP QA or clinical quality leadership roles, with demonstrated experience leading and hosting regulatory inspections (e.g., FDA BIMO, EMA, MHRA, PMDA).
Mercy Brown Bag - Executive Director Transforming Age AssociatesMercy Brown Bag - Executive DirectorOakland, California$140,000–$170,000 / yearManages, leads, and develops staff to include Food Recovery Program Consultant and Assistant Director, who in turn oversees External and Internal Operations Managers, Development, Volunteer Manager, and all warehouse, and food distribution team members. Collaborates with team and key stakeholders and team and key stakeholders to formulate and effectively communicate the impact of MBBP, backed by key data and visual tools.
NewExecutive Director, Market Access Allogene TherapeuticsExecutive Director, Market AccessSouth San Francisco, CARemote$280,000–$320,000 / yearGiven the unique complexities of CAR T therapy, this role will play a critical part in addressing site-of-care dynamics, center-of-excellence (COE) networks, single case agreements, and innovative payment models to enable broad access across both academic and community oncology settings. Led by a management team with significant experience in cell therapy, Allogene is developing a pipeline of “off-the-shelf” CAR T cell product candidates with the goal of delivering readily available cell therapy on-demand, more reliably, and at greater scale to more patients.
Executive Director, Biologics Innovation & Strategy Exelixis Inc.Executive Director, Biologics Innovation & StrategyAlameda, CA$268,500–$380,500 / yearSuperlative Interaction and collaboration skills and communications across multiple departments and functions in both research and development parts of the organization as well as the ability to represent Exelixis with external collaboration colleagues to discuss and resolve project needs and issues in research and development of biotherapeutics. As a member of the Biotherapeutics team, the Executive Director of Biologics Innovation & Strategy plays a key role in leading the efforts for advancing the development of antibody drug conjugates (ADCs) and other biologics for oncology-based molecules at Exelixis.
NewExecutive Director, Scientific Publications (Oncology) Exelixis Inc.Executive Director, Scientific Publications (Oncology)Alameda, CA$273,000–$388,000 / yearResponsibilities include management of the Publications team, oversight of publication planning for each Exelixis development compound, coordination of publication planning and tactical execution with cross-functional collaborators, contribution to publication project execution as needed, management of publication vendors and responsibility for compliance aspects of the publication function. EDUCATION/EXPERIENCE/KNOWLEDGE & SKILLS: Education/Experience: Doctorate level degree (PharmD, MD, PhD) with a minimum of 15 years of related experience; or, Master's level degree in related discipline and a minimum of 16 years of related experience; or, Bachelor's level degree in related discipline and a minimum of 18 years of related experience; or, Equivalent combination of education and experience.
Mercy Brown Bag - Executive Director Transforming AgeMercy Brown Bag - Executive DirectorOakland, CaliforniaManages, leads, and develops staff to include Food Recovery Program Consultant and Assistant Director, who in turn oversees External and Internal Operations Managers, Development, Volunteer Manager, and all warehouse, and food distribution team members. Collaborates with team and key stakeholders and team and key stakeholders to formulate and effectively communicate the impact of MBBP, backed by key data and visual tools.
Executive Director, Gxp Quality And Compliance Revolution Medicines, Inc.Executive Director, Gxp Quality And ComplianceRedwood City, CA$265,000–$331,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Preferred Skills: Experience leading global GxP compliance programs across both clinical development and commercial product environments, including inspection readiness, launch readiness, and post-approval compliance oversight.
Executive Director Potrero GroupExecutive DirectorSan Francisco, CaliforniaThis role requires a strong communicator who can engage diverse audiences from scientific experts to community groups, and translate complex science into compelling narratives. The incoming Executive Director will lead a thriving organization known for its rigorous, unbiased scientific research and strong regional partnerships during an exciting period of growth.
Executive Director of Campus Operations - Administration and Finance 2021. All Rights Reserved. A California State University CampusExecutive Director of Campus Operations - Administration and FinanceVallejo, CaliforniaThe Administration and Finance Division plays a vital role in supporting the university’s operational backbone, encompassing areas such as finance, budgeting, facilities, public safety, environmental health and safety, procurement, University Housing, Information Technology Services, Performing Arts Center, Cal Poly Partners, and divisional operations. The SVP of Administration and Finance reports directly to the University President and serves as a member of the President’s Cabinet, working collaboratively with other university divisions to advance strategic initiatives, ensure financial sustainability, and maintain a safe, inclusive, and well-functioning campus environment.
Executive Director, Computational Systems Biology Revolution Medicines, Inc.Executive Director, Computational Systems BiologyRedwood City, CA$265,000–$331,000 / yearThe individual will lead a team of computational biologists and bioinformaticians focused on acquisition, organization, and analysis of large multi-omics data sets, using both public and proprietary data sources, that will help inform treatment strategies and guide patient stratification for a growing pipeline of RAS(ON) and targeted oncology therapeutics. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Executive Director, Clinical Supply Chain Revolution Medicines, Inc.Executive Director, Clinical Supply ChainRedwood City, CA$265,000–$331,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Executive Director, Early Clinical Development Revolution Medicines, Inc.Executive Director, Early Clinical DevelopmentRedwood City, CA$265,000–$331,000 / yearHas demonstrated collaborate behaviors on enterprise-level strategic initiatives with a variety of internal and external partners and stakeholders - including clinical investigators/clinicians, scientists and key opinion leaders (KOLs), as well as internal groups, including other groups in development, research, business development, commercial, legal, etc. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Executive Director, Clinical Development Revolution Medicines, Inc.Executive Director, Clinical DevelopmentRedwood City, CA$265,000–$331,000 / yearHas demonstrated collaborate behaviors on enterprise-level strategic initiatives with a variety of internal and external partners and stakeholders - including clinical investigators/clinicians, scientists and key opinion leaders (KOLs), as well as internal groups, including other groups in development, research, business development, commercial, legal, etc. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.